KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zoetis (ZTS) Research & Development (2016 - 2025)

Zoetis (ZTS) has disclosed Research & Development for 12 consecutive years, with $170.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Research & Development changed N/A to $170.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $685.0 million, a N/A change, with the full-year FY2024 number at $686.0 million, up 11.73% from a year prior.
  • Research & Development was $170.0 million for Q3 2025 at Zoetis, down from $172.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $186.0 million in Q4 2024 to a low of $118.0 million in Q1 2021.
  • A 4-year average of $149.4 million and a median of $146.0 million in 2023 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: grew 17.86% in 2021, then decreased 3.09% in 2025.
  • Zoetis' Research & Development stood at $138.0 million in 2021, then grew by 5.8% to $146.0 million in 2023, then rose by 27.4% to $186.0 million in 2024, then dropped by 8.6% to $170.0 million in 2025.
  • Per Business Quant, the three most recent readings for ZTS's Research & Development are $170.0 million (Q3 2025), $172.0 million (Q2 2025), and $157.0 million (Q1 2025).